المؤلفون: Giacomelli A; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.; III Infectious Diseases Unit, Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Luigi Sacco Hospital, Legnano (MI), Italy., Conti F; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.; III Infectious Diseases Unit, Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Luigi Sacco Hospital, Legnano (MI), Italy., Pezzati L; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.; III Infectious Diseases Unit, Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Luigi Sacco Hospital, Legnano (MI), Italy., Oreni L; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy., Ridolfo AL; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.; III Infectious Diseases Unit, Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Luigi Sacco Hospital, Legnano (MI), Italy., Morena V; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.; III Infectious Diseases Unit, Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Luigi Sacco Hospital, Legnano (MI), Italy., Bonazzetti C; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.; III Infectious Diseases Unit, Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Luigi Sacco Hospital, Legnano (MI), Italy., Pagani G; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.; III Infectious Diseases Unit, Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Luigi Sacco Hospital, Legnano (MI), Italy.; Infectious Diseases Unit, Legnano General Hospital, ASST Ovest Milanese, Via G.B. Grassi 74, 20157, Milan, Italy., Formenti T; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy., Galli M; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy.; III Infectious Diseases Unit, Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Luigi Sacco Hospital, Legnano (MI), Italy., Rusconi S; Department of Infectious Diseases, ASST Fatebenefratelli-Sacco, Luigi Sacco University Hospital, Milan, Italy. stefano.rusconi@unimi.it.; III Infectious Diseases Unit, Luigi Sacco Department of Biomedical and Clinical Sciences DIBIC, University of Milan, Luigi Sacco Hospital, Legnano (MI), Italy. stefano.rusconi@unimi.it.

المصدر: BMC infectious diseases [BMC Infect Dis] 2021 Jun 22; Vol. 21 (1), pp. 595. Date of Electronic Publication: 2021 Jun 22.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Anti-HIV Agents/*therapeutic use , Dideoxynucleosides/*therapeutic use , Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/*therapeutic use , Emtricitabine, Rilpivirine, Tenofovir Drug Combination/*therapeutic use , HIV Infections/*drug therapy , Heterocyclic Compounds, 3-Ring/*therapeutic use , Lamivudine/*therapeutic use , Oxazines/*therapeutic use , Piperazines/*therapeutic use , Pyridones/*therapeutic use, Adult ; Anti-HIV Agents/metabolism ; Body Weight/drug effects ; Cohort Studies ; Dideoxynucleosides/metabolism ; Drug Combinations ; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/metabolism ; Emtricitabine, Rilpivirine, Tenofovir Drug Combination/metabolism ; Female ; Heart Disease Risk Factors ; Heterocyclic Compounds, 3-Ring/metabolism ; Humans ; Italy/epidemiology ; Lamivudine/metabolism ; Lipid Metabolism/drug effects ; Lipids/blood ; Male ; Middle Aged ; Oxazines/metabolism ; Piperazines/metabolism ; Pyridones/metabolism ; Retrospective Studies ; Tablets/therapeutic use

المؤلفون: Gys C; Toxicological Center, University of Antwerp, Universiteitsplein 1, 2610, Antwerp, Belgium., Mortelé O; Laboratorium for Clinical Biology, GZA Sint-Augustinus, Oosterveldlaan 24, 2610, Antwerp, Belgium., van Rafelghem B; Department of Forensic Medicine, Antwerp University Hospital, University of Antwerp, Drie Eikenstraat 655, 2650 Edegem, Belgium., Berry E; Toxicological Center, University of Antwerp, Universiteitsplein 1, 2610, Antwerp, Belgium., van Nuijs ALN; Toxicological Center, University of Antwerp, Universiteitsplein 1, 2610, Antwerp, Belgium., Lambert W; Laboratory of Toxicology, Department of Bioanalysis, Faculty of Pharmaceutical Sciences, Ghent University, Ottergemsesteenweg 460, 9000, Ghent, Belgium., Jacobs W; Department of Forensic Medicine, Antwerp University Hospital, University of Antwerp, Drie Eikenstraat 655, 2650 Edegem, Belgium., Schouwers S; Laboratorium for Clinical Biology, GZA Sint-Augustinus, Oosterveldlaan 24, 2610, Antwerp, Belgium., Meskal A; Laboratorium for Clinical Biology, GZA Sint-Augustinus, Oosterveldlaan 24, 2610, Antwerp, Belgium., Van Hemeldonck E; Department of Intensive Care, GZA Sint-Augustinus, Oosterveldlaan 24, 2610, Antwerp, Belgium., Heytens L; Department of Intensive Care, GZA Sint-Augustinus, Oosterveldlaan 24, 2610, Antwerp, Belgium., Neels H; Toxicological Center, University of Antwerp, Universiteitsplein 1, 2610, Antwerp, Belgium., Covaci A; Toxicological Center, University of Antwerp, Universiteitsplein 1, 2610, Antwerp, Belgium.

المصدر: Journal of analytical toxicology [J Anal Toxicol] 2023 Feb 21; Vol. 47 (1), pp. e1-e5.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: Oxford University Press Country of Publication: England NLM ID: 7705085 Publication Model: Print Cited Medium: Internet ISSN: 1945-2403 (Electronic) Linking ISSN: 01464760 NLM ISO Abbreviation: J Anal Toxicol Subsets: MEDLINE

مواضيع طبية MeSH: Anti-HIV Agents*/toxicity , Anti-HIV Agents*/therapeutic use , HIV Infections*/drug therapy , Drug Overdose*, Humans ; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/therapeutic use ; HIV ; Drug Combinations ; Emtricitabine/toxicity ; Emtricitabine/therapeutic use

المؤلفون: Dickson S; West Health Policy Center, Washington, DC., Gabriel N; Division of Clinical Pharmacy, University of California, San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, CA, USA., Hernandez I; Division of Clinical Pharmacy, University of California, San Diego, Skaggs School of Pharmacy and Pharmaceutical Sciences, La Jolla, CA, USA.

المصدر: AIDS (London, England) [AIDS] 2022 Dec 01; Vol. 36 (15), pp. 2225-2227. Date of Electronic Publication: 2022 Oct 06.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 8710219 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5571 (Electronic) Linking ISSN: 02699370 NLM ISO Abbreviation: AIDS Subsets: MEDLINE

مواضيع طبية MeSH: Emtricitabine, Rilpivirine, Tenofovir Drug Combination*/therapeutic use , HIV Infections*/drug therapy , Anti-HIV Agents*/therapeutic use, Humans ; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/therapeutic use ; Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/therapeutic use ; Tenofovir/therapeutic use

المؤلفون: Huang M; Department of Neurology, Neurological Institute, Cleveland Clinic, Cleveland, OH; and., Prayson RA; Department of Pathology, Cleveland Clinic, Cleveland, OH., Li Y; Department of Neurology, Neurological Institute, Cleveland Clinic, Cleveland, OH; and.

المصدر: Journal of clinical neuromuscular disease [J Clin Neuromuscul Dis] 2022 Dec 01; Vol. 24 (2), pp. 75-79.

نوع المنشور: Review; Case Reports; Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 100887391 Publication Model: Print Cited Medium: Internet ISSN: 1537-1611 (Electronic) Linking ISSN: 15220443 NLM ISO Abbreviation: J Clin Neuromuscul Dis Subsets: MEDLINE

مواضيع طبية MeSH: Muscular Diseases*/chemically induced , HIV Infections*/complications , HIV Infections*/drug therapy, Female ; Humans ; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/therapeutic use ; Simvastatin/adverse effects ; Creatine Kinase

عنوان ترانسليتريتد: Fallbericht über die Erstdiagnose einer HIV-Erkrankung eines jungen Seemanns durch 2 AIDS-definierende Erkrankungen mit letalem Intensivverlauf.

المؤلفون: Herpertz G; Klinik für Anästhesie und chirurgische Intensivmedizin, Klinikum Bremerhaven-Reinkenheide, Bremerhaven., Haerting M; Krankenhausapotheke, Klinikum Bremerhaven-Reinkenheide, Bremerhaven.; Antibiotic Stewardship Team, Klinikum Bremerhaven-Reinkenheide, Bremerhaven., Radke O; Klinik für Anästhesie und chirurgische Intensivmedizin, Klinikum Bremerhaven-Reinkenheide, Bremerhaven.

المصدر: Deutsche medizinische Wochenschrift (1946) [Dtsch Med Wochenschr] 2022 Oct; Vol. 147 (20), pp. 1330-1335. Date of Electronic Publication: 2022 Oct 04.

نوع المنشور: Case Reports; Journal Article

بيانات الدورية: Publisher: G. Thieme Country of Publication: Germany NLM ID: 0006723 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1439-4413 (Electronic) Linking ISSN: 00120472 NLM ISO Abbreviation: Dtsch Med Wochenschr Subsets: MEDLINE

مواضيع طبية MeSH: Acquired Immunodeficiency Syndrome*/complications , Acquired Immunodeficiency Syndrome*/diagnosis , Acquired Immunodeficiency Syndrome*/drug therapy , HIV Infections*/complications , HIV Infections*/diagnosis , HIV Infections*/drug therapy , Military Personnel* , Pneumonia, Pneumocystis*/drug therapy, Adult ; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/therapeutic use ; Ganciclovir/therapeutic use ; Humans ; Meropenem/therapeutic use ; Moxifloxacin/therapeutic use

المؤلفون: Naccarato MJ; 1 Department of Pharmacy, St Michael's Hospital, Toronto, Ontario, Canada.; 2 Division of Infectious Diseases, St Michael's Hospital, Toronto, Ontario, Canada., Yoong DM; 1 Department of Pharmacy, St Michael's Hospital, Toronto, Ontario, Canada.; 2 Division of Infectious Diseases, St Michael's Hospital, Toronto, Ontario, Canada., Fong IW; 2 Division of Infectious Diseases, St Michael's Hospital, Toronto, Ontario, Canada., Gough KA; 2 Division of Infectious Diseases, St Michael's Hospital, Toronto, Ontario, Canada.; 3 Department of Medicine, University of Toronto, Toronto, Ontario, Canada., Ostrowski MA; 2 Division of Infectious Diseases, St Michael's Hospital, Toronto, Ontario, Canada.; 3 Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; 4 Keenan Research Centre for Biomedical Science, St Michael's Hospital, Toronto, Ontario, Canada., Tan DHS; 2 Division of Infectious Diseases, St Michael's Hospital, Toronto, Ontario, Canada.; 3 Department of Medicine, University of Toronto, Toronto, Ontario, Canada.; 5 Centre for Research on Inner City Health, St Michael's Hospital, Toronto, Ontario, Canada.; 6 Institute for Health Policy, Management and Evaluation, University of Toronto, Toronto, Ontario, Canada.

المصدر: Journal of the International Association of Providers of AIDS Care [J Int Assoc Provid AIDS Care] 2018 Jan-Dec; Vol. 17, pp. 2325957417752260.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Sage Publications Country of Publication: United States NLM ID: 101603896 Publication Model: Print Cited Medium: Internet ISSN: 2325-9582 (Electronic) Linking ISSN: 23259574 NLM ISO Abbreviation: J Int Assoc Provid AIDS Care Subsets: MEDLINE

مواضيع طبية MeSH: Anti-HIV Agents/*administration & dosage , Darunavir/*administration & dosage , Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/*administration & dosage , HIV Infections/*drug therapy, Adult ; Anti-HIV Agents/therapeutic use ; Darunavir/therapeutic use ; Drug Administration Schedule ; Drug Resistance, Viral ; Drug Therapy, Combination ; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/therapeutic use ; Female ; HIV-1 ; Humans ; Male ; Middle Aged ; Retrospective Studies

المؤلفون: Spinner CD; Department of Medicine II, University Hospital Klinikum rechts der Isar, Munich, Germany., Schulz S; Department of Medicine II, University Hospital Klinikum rechts der Isar, Munich, Germany., Bauer U; Department of Medicine II, University Hospital Klinikum rechts der Isar, Munich, Germany., Schneider J; Department of Medicine II, University Hospital Klinikum rechts der Isar, Munich, Germany., Bobardt J; Department of Medicine II, University Hospital Klinikum rechts der Isar, Munich, Germany., Von Werder A; Department of Medicine II, University Hospital Klinikum rechts der Isar, Munich, Germany., Schmid RM; Department of Medicine II, University Hospital Klinikum rechts der Isar, Munich, Germany., Zink A; Department I of Dermatology and Allergology, University Hospital Klinikum rechts der Isar, Munich, Germany., Wolf E; MUC Research, Munich, Germany., Iakoubov R; Department of Medicine II, University Hospital Klinikum rechts der Isar, Munich, Germany.

المصدر: Antiviral therapy [Antivir Ther] 2018; Vol. 23 (7), pp. 629-632. Date of Electronic Publication: 2018 Oct 03.

نوع المنشور: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: SAGE Publications Country of Publication: England NLM ID: 9815705 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2040-2058 (Electronic) Linking ISSN: 13596535 NLM ISO Abbreviation: Antivir Ther Subsets: MEDLINE

مواضيع طبية MeSH: Anti-HIV Agents/*pharmacokinetics , Blood Glucose/*metabolism , Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/*pharmacokinetics , Insulin Resistance/*physiology , Rilpivirine/*pharmacokinetics, Adenine/analogs & derivatives ; Adult ; Anti-HIV Agents/blood ; Body Weight ; Drug Combinations ; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/blood ; Emtricitabine ; Glucose Clamp Technique ; Healthy Volunteers ; Humans ; Male ; Prospective Studies ; Rilpivirine/blood ; Tenofovir

المؤلفون: Mayer KH; The Fenway Institute, Fenway Health, Boston, MA;†Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA;‡Department of Medicine, Harvard Medical School, Boston, MA;§Proctor Foundation, University of California San Francisco, San Francisco, CA;‖Department of Medicine, Albert Einstein College of Medicine, Bronx, NY;Departments of ¶Epidemiology;#Behavioral and Social Health Sciences; and**Psychiatry and Human Behavior, Brown University, Providence, RI., Jones D, Oldenburg C, Jain S, Gelman M, Zaslow S, Grasso C, Mimiaga MJ

المصدر: Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2017 Aug 15; Vol. 75 (5), pp. 535-539.

نوع المنشور: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural

بيانات الدورية: Publisher: Lippincott Williams & Wilkins, Inc Country of Publication: United States NLM ID: 100892005 Publication Model: Print Cited Medium: Internet ISSN: 1944-7884 (Electronic) Linking ISSN: 15254135 NLM ISO Abbreviation: J Acquir Immune Defic Syndr Subsets: MEDLINE

مواضيع طبية MeSH: Anti-HIV Agents/*administration & dosage , Anti-HIV Agents/*therapeutic use , Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/*administration & dosage , Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/*therapeutic use , HIV Infections/*drug therapy , Post-Exposure Prophylaxis/*methods, Adult ; Anti-HIV Agents/adverse effects ; Boston ; CD4 Lymphocyte Count ; Drug Administration Schedule ; Drug Therapy, Combination ; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/adverse effects ; Female ; HIV Infections/prevention & control ; Humans ; Male ; Medication Adherence ; Prospective Studies ; Treatment Outcome ; Viral Load

المؤلفون: Valin N; Hôpital Saint-Antoine, Service des Maladies Infectieuses et Tropicales, 184 rue du Faubourg Saint-Antoine, F75571, Paris Cedex 12, France. nadia.valin@aphp.fr., Fonquernie L; Hôpital Saint-Antoine, Service des Maladies Infectieuses et Tropicales, 184 rue du Faubourg Saint-Antoine, F75571, Paris Cedex 12, France., Daguenel A; Hôpital Saint-Antoine, Service Pharmacie, 184 rue du Faubourg Saint-Antoine, F75571, Paris Cedex 12, France., Campa P; Hôpital Saint-Antoine, Service des Maladies Infectieuses et Tropicales, 184 rue du Faubourg Saint-Antoine, F75571, Paris Cedex 12, France., Anthony T; Hôpital Saint-Antoine, Service des Maladies Infectieuses et Tropicales, 184 rue du Faubourg Saint-Antoine, F75571, Paris Cedex 12, France., Guiguet M; Sorbonne Universités, UPMC Univ Paris 06, INSERM, Institut Pierre Louis d'Epidemiologie et de Santé Publique (IPLESP UMRS 1136), F75013, Paris, France., Girard PM; Hôpital Saint-Antoine, Service des Maladies Infectieuses et Tropicales, 184 rue du Faubourg Saint-Antoine, F75571, Paris Cedex 12, France.; Sorbonne Universités, UPMC Univ Paris 06, INSERM, Institut Pierre Louis d'Epidemiologie et de Santé Publique (IPLESP UMRS 1136), F75013, Paris, France., Meyohas MC; Hôpital Saint-Antoine, Service des Maladies Infectieuses et Tropicales, 184 rue du Faubourg Saint-Antoine, F75571, Paris Cedex 12, France.; Sorbonne Universités, UPMC Univ Paris 06, F75005, Paris, France.

المصدر: BMC infectious diseases [BMC Infect Dis] 2016 Nov 29; Vol. 16 (1), pp. 718. Date of Electronic Publication: 2016 Nov 29.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2334 (Electronic) Linking ISSN: 14712334 NLM ISO Abbreviation: BMC Infect Dis Subsets: MEDLINE

مواضيع طبية MeSH: Anti-HIV Agents/*adverse effects , Anti-HIV Agents/*therapeutic use , Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/*therapeutic use , HIV Infections/*prevention & control , Post-Exposure Prophylaxis/*methods, Adolescent ; Adult ; Aged ; Anti-HIV Agents/administration & dosage ; Cobicistat ; Drug Combinations ; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/administration & dosage ; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/adverse effects ; Female ; HIV Infections/drug therapy ; Homosexuality, Male ; Humans ; Male ; Medication Adherence ; Middle Aged ; Paris ; Prospective Studies ; Sexual Behavior ; Young Adult

المؤلفون: Biagi M; 1 Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA., Badowski ME; 1 Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA., Chiampas T; 1 Department of Pharmacy Practice, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, USA., Young J; 2 Section of Infectious Diseases, College of Medicine, University of Illinois at Chicago, Chicago, IL, USA., Patel M; 2 Section of Infectious Diseases, College of Medicine, University of Illinois at Chicago, Chicago, IL, USA., Vaughn P; 3 Department of Medicine, University of Illinois at Chicago, Chicago, IL, USA.

المصدر: International journal of STD & AIDS [Int J STD AIDS] 2017 Jul; Vol. 28 (8), pp. 766-772. Date of Electronic Publication: 2016 Sep 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Sage Country of Publication: England NLM ID: 9007917 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1758-1052 (Electronic) Linking ISSN: 09564624 NLM ISO Abbreviation: Int J STD AIDS Subsets: MEDLINE

مواضيع طبية MeSH: Anti-HIV Agents/*administration & dosage , Atazanavir Sulfate/*administration & dosage , Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/*administration & dosage , HIV Infections/*drug therapy , HIV Protease Inhibitors/*administration & dosage, Adult ; Anti-HIV Agents/therapeutic use ; Atazanavir Sulfate/therapeutic use ; Drug Combinations ; Drug Therapy, Combination ; Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination/therapeutic use ; Female ; HIV Protease Inhibitors/therapeutic use ; Humans ; Male ; Middle Aged ; Treatment Outcome